| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | acetylcholinesterase | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adenosine a1 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adenosine a2a receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adenosine a3 receptor | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adrenergic receptor alpha-1a | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adrenergic receptor alpha-1b | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adrenergic receptor alpha-1d | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adrenergic receptor alpha-2a | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | adrenergic receptor beta-1 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | gastrin/cholecystokinin type b receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | muscarinic acetylcholine receptor m1 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | muscarinic acetylcholine receptor m2 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | muscarinic acetylcholine receptor m3 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | muscarinic acetylcholine receptor m4 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | muscarinic acetylcholine receptor m5 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | neuronal acetylcholine receptor alpha-4 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | neuronal acetylcholine receptor beta-2 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | cannabinoid receptor 1 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | dopamine d1 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | dopamine d2 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | dopamine d3 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | endothelin a receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | histamine h1 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | histamine h2 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | histamine h3 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | 5-ht 1a receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | 5-ht 2a receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | 5-ht 2b receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | 5-ht 2c receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | 5-ht 3a receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | 5-ht 4 receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | 5-ht 7 receptor | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | melanocortin receptor 4 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | melatonin receptor type 1a | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | neuropeptide y receptor type 1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | glucocorticoid receptor messenger rna | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | neurotensin receptor type 1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | opioid receptor mu | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | norepinephrine transporter | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | dopamine transporter | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | serotonin transporter | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | substance-p receptor | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | substance-k receptor | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| click here to return to the previous page | ||||||||